Martin Patricia A.

CIK 00019167642 companiesCAMBRIDGE, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001916764

Recent Transactions

30 trades

Sale
CYPHERPUNK TECHNOLOGIES INC.$CYPH
Common Stock
2026-09-23$3.86/sh−50,000→ 118,750 total
Award
AN2 Therapeutics, Inc.$ANTX
Common Stock
2026-07-10+766→ 18,863 total
Award
CYPHERPUNK TECHNOLOGIES INC.$CYPH
Restricted Stock Units
2026-07-01−75,000→ 75,000 total
Award
AN2 Therapeutics, Inc.$ANTX
Common Stock
2026-04-10+1,192→ 18,097 total
Disposition to Issuer
AN2 Therapeutics, Inc.$ANTX
Stock Option (right to buy)
2026-03-19−24,999→ 0 total
Disposition to Issuer
AN2 Therapeutics, Inc.$ANTX
Stock Option (right to buy)
2026-03-19−23,742→ 0 total
Award
AN2 Therapeutics, Inc.$ANTX
Stock Option (right to buy)
2026-03-19+23,742→ 23,742 total
Disposition to Issuer
AN2 Therapeutics, Inc.$ANTX
Stock Option (right to buy)
2026-03-19−10,362→ 0 total
Award
AN2 Therapeutics, Inc.$ANTX
Stock Option (right to buy)
2026-03-19+24,999→ 24,999 total
Award
AN2 Therapeutics, Inc.$ANTX
Stock Option (right to buy)
2026-03-19+10,362→ 10,362 total
Exercise/Conversion
CYPHERPUNK TECHNOLOGIES INC.$CYPH
Restricted Stock Units
2026-03-13−74,700→ 0 total
Exercise/Conversion
CYPHERPUNK TECHNOLOGIES INC.$CYPH
Restricted Stock Units
2026-03-13−94,050→ 0 total
Exercise/Conversion
CYPHERPUNK TECHNOLOGIES INC.$CYPH
Common Stock
2026-03-13+74,700→ 74,700 total
Exercise/Conversion
CYPHERPUNK TECHNOLOGIES INC.$CYPH
Common Stock
2026-03-13+94,050→ 168,750 total
Award
AN2 Therapeutics, Inc.$ANTX
Stock Option (Right to Buy)
2026-02-20+20,400→ 20,400 total
Award
AN2 Therapeutics, Inc.$ANTX
Common Stock
2026-01-12+3,650→ 16,905 total
Award
CYPHERPUNK TECHNOLOGIES INC.$CYPH
Restricted Stock Units
2025-12-23+94,050→ 94,050 total
Award
CYPHERPUNK TECHNOLOGIES INC.$CYPH
Restricted Stock Units
2025-11-11+74,700→ 74,700 total
Award
AN2 Therapeutics, Inc.$ANTX
Common Stock
2025-10-10+3,274→ 13,255 total
Award
AN2 Therapeutics, Inc.$ANTX
Common Stock
2025-07-10+3,750→ 9,981 total
Award
AN2 Therapeutics, Inc.$ANTX
Stock Option (Right to Buy)
2025-05-22+19,111→ 19,111 total
Award
AN2 Therapeutics, Inc.$ANTX
Common Stock
2025-04-10+3,065→ 6,231 total
Award
AN2 Therapeutics, Inc.$ANTX
Common Stock
2024-12-19+3,166→ 3,166 total
Award
CYPHERPUNK TECHNOLOGIES INC.$CYPH
Stock Option (Right to Buy)
2024-10-02+25,000→ 25,000 total
Award
AN2 Therapeutics, Inc.$ANTX
Stock Option (Right to Buy)
2024-06-19+64,503→ 64,503 total
Award
CYPHERPUNK TECHNOLOGIES INC.$CYPH
Stock Option (Right to Buy)
2024-01-29+25,000→ 25,000 total
Award
CYPHERPUNK TECHNOLOGIES INC.$CYPH
Stock Option (Right to Buy)
2023-08-23+15,000→ 15,000 total
Award
AN2 Therapeutics, Inc.$ANTX
Stock Option (right to buy)
2023-06-07+23,742→ 23,742 total
Award
CYPHERPUNK TECHNOLOGIES INC.$CYPH
Stock Option (Right to Buy)
2023-03-31+150,000→ 150,000 total
Award
AN2 Therapeutics, Inc.$ANTX
Stock Option (right to buy)
2022-05-12+10,362→ 10,362 total

Companies

Recent Filings

Address

C/O CYPHERPUNK TECHNOLOGIES INC. 47 THORNDIKE STREET, SUITE B1-1

CAMBRIDGE, MA, 02141

View on SEC.gov